Article Information
History
- January 4, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Aartik Sarma1,
- Stephanie A. Christenson1,
- Eran Mick1,2,3,
- Catherine DeVoe2,
- Thomas Deiss2,
- Angela Oliveira Pisco3,
- Rajani Ghale1,2,
- Alejandra Jauregui2,
- Ashley Byrne3,
- Farzad Moazed1,
- Natasha Spottiswoode4,
- Pratik Sinha5,
- Beth Shoshana Zha1,
- Paula Hayakawa Serpa2,3,
- K. Mark Ansel7,8,
- Jennifer G. Wilson9,
- Aleksandra Leligdowicz2,
- Emily R. Siegel10,
- Marina Sirota11,
- Joseph L. DeRisi3,6,
- Michael A. Matthay1,
- COMET Consortium+,
- Carolyn M. Hendrickson1,
- Kirsten N. Kangelaris4,
- Matthew F. Krummel12,
- Prescott G. Woodruff1,8,
- David J. Erle4,13,14,
- Carolyn S. Calfee*,1 and
- Charles R. Langelier*,‡,2,3
- 1Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, University of California, San Francisco, CA, USA
- 2Division of Infectious Diseases, University of California, San Francisco, CA, USA
- 3Chan Zuckerberg Biohub, San Francisco, CA, USA
- 4Department of Medicine, University of California, San Francisco, CA, USA
- 5Department of Anesthesia, Washington University, Saint Louis, Missouri, MO, USA
- 6Department of Biochemistry and Biophysics, University of California, San Francisco, CA, USA
- 7Department of Microbiology and Immunology, University of California, San Francisco, CA, USA
- 8Sandler Asthma Basic Research Center, University of California, San Francisco, CA, USA
- 9Department of Emergency Medicine, Stanford University, Palo Alto, CA, USA
- 10School of Medicine, University of California, San Francisco, CA, USA
- 11Division of Rheumatology, University of California, San Francisco, CA, USA
- 12Department of Pathology, University of California, San Francisco, CA, USA
- 13Lung Biology Center, University of California, San Francisco, CA, USA
- 14UCSF CoLabs, University of California, San Francisco, CA, USA
- ↵‡Correspondence: chaz.langelier{at}ucsf.edu
↵* These authors contributed equally
Posted January 04, 2021.
COVID-19 ARDS is characterized by a dysregulated host response that differs from cytokine storm and may be modified by dexamethasone
